However, to the best of our knowledge, the current study provides limited evidence to investigate the role of p16 cytoplasmic staining in patients with HNSCC who received TPF induction chemotherapy; our findings may demonstrate the predictive and prognostic role of p16 cytoplasmic staining in these patients in clinical practice. Here, CDKN2A is linked to head and neck squamous cell carcinoma.